Application Detail
Status
ClosedDescription of Medical Service
This proposal is for the provision of an MBS item for bone densitometry by DXA for women with breast cancer who receive, or are being considered for, treatment with aromatase inhibitors.Description of Medical Condition
In hormone receptor-positive breast cancer the proliferation of mammary carcinoma cells is dependent on oestrogen. Common therapies for hormone receptor positive breast cancer include aromatase inhibitors and tamoxifen. The aromatase inhibitors have a negative impact on bone density due to the inhibition of overall oestrogen production within the bodyReason for Application
-Medical Service Type
-Previous Application Number
Not ApplicableAssociated Documentation
Application Form
-PICO Confirmation
Final Protocol (PDF 611 KB)Final Protocol (Word 240 KB)
Assessment Report
Final Assessment Report (PDF 877 KB)Final Assessment Report (Word 1020 KB)
Public Summary Document
PSD from November 2014Public Summary Document (PDF 442 KB)
Public Summary Document (Word 279 KB)
PSD from July 2015
Public Summary Document (PDF 1401 KB)
Public Summary Document (Word 357 KB)
Meetings for this Application
PASC
16 to 17 August 201213 to 14 December 2012
ESC
12 to 13 June 201411 to 12 June 2015
MSAC
26 to 28 November 201430 to 31 July 2015